Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Income from Continuing Operations (2016 - 2026)

Ekso Bionics Holdings has reported Income from Continuing Operations over the past 14 years, most recently at 4664000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 103.76% to 4664000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 13636000.0, a 27.09% decrease, with the full-year FY2025 number at 13635000.0, down 27.09% from a year prior.
  • Income from Continuing Operations reached 4664000.0 in Q4 2025 per EKSO's latest filing, down from 1420000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 1420000.0 in Q3 2025, with the low at 4664000.0 in Q4 2025.
  • The 5-year median for Income from Continuing Operations is 3443500.0 (2021), against an average of 3471650.0.
  • The largest YoY upside for Income from Continuing Operations was 47.76% in 2025 against a maximum downside of 103.76% in 2025.
  • Tracing EKSO's Income from Continuing Operations over 5 years: stood at 4588000.0 in 2021, then grew by 1.87% to 4502000.0 in 2022, then increased by 21.92% to 3515000.0 in 2023, then surged by 34.88% to 2289000.0 in 2024, then plummeted by 103.76% to 4664000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 4664000.0, 1420000.0, and 4040000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.